Malaria
FILE - In this Aug. 3, 2020, file photo, Oklahoma Attorney Gen. Mike Hunter speaks during a news conference in Oklahoma City. Hunter has secured a $2.6 million refund for the purchase of a malaria drug once touted by President Donald Trump as an effective treatment for COVID-19. Hunter announced the agreement on Friday, May 7, 2021, with California-based FFF Enterprises. (AP Photo/Sue Ogrocki, File)
Oklahoma AG secures $2.6M refund for malaria drug purchase

By Sean Murphy May. 07, 2021 12:42 PM EDT

FILE - In this Feb. 21, 2017, file photo, Oklahoma Attorney General Mike Hunter sits at a meeting in Oklahoma City. The Oklahoma Attorney General's Office is attempting to return $2 million worth of an anti-malaria drug once touted by former President Donald Trump as an effective treatment for COVID-19, a spokesman said Wednesday, Jan. 27, 2021. (AP Photo/Sue Ogrocki, File)
Oklahoma seeking to return $2M worth of hydroxychloroquine

By Sean Murphy Jan. 27, 2021 12:15 PM EST

In this image provided by Public Health Emergency, a department of Health and Human Services, Rick Bright is shown in his official photo on April 27, 2017, in Washington. (Health and Human Services via AP)
Whistleblower who alleged White House virus failures resigns

By Ricardo Alonso-Zaldivar Oct. 06, 2020 07:01 PM EDT

White House trade adviser Peter Navarro speaks with reporters outside the West Wing at the White House in Washington, Monday, July 27, 2020. (AP Photo/Andrew Harnik)
Trump defends disproved COVID-19 treatment

By Darlene Superville And Amanda Seitz Jul. 28, 2020 10:27 AM EDT

A women's movement activist holds a sign that reads in Portuguese "Genocide 60 thousand deaths, Bolsonaro out," during a protest against the government's inefficiency in the face of the new coronavirus pandemic and the ongoing police brutality against blacks, in front of the National Congress, in Brasilia, Brazil, Thursday, July 2, 2020. (AP Photo/Eraldo Peres)
Bolsonaro now 'poster boy' for dubious COVID-19 treatment

By David Biller, Marcelo De Sousa And Mauricio Savarese Jul. 09, 2020 12:02 AM EDT

FILE - In this April 9, 2019 file photo, Brazil's President Jair Bolsonaro speaks during a swearing-in ceremony at the Planalto Presidential Palace, in Brasilia, Brazil. Bolsonaro’s latest education minister offered his resignation Tuesday, June 30, 2020, just days after his appointment, creating a new headache for the embattled leader as he struggles to start a new chapter at the ministry and shore up flagging support. (AP Photo/Eraldo Peres, File)
Bolsonaro becomes 'poster boy' for unproven virus treatment

By David Biller, Marcelo De Sousa And Mauricio Savarese Jul. 08, 2020 07:59 PM EDT

THIS CORRECTS THE SPELLING OF THE LAST NAME TO KELLEY, AND NOT KELLY AS ORIGINALLY SENT - Doris Kelley, 57, sits in her home on Monday, June 29, 2020 in Ruffs Dale, Pa. Kelley was one of the first patients in a UPMC trial for COVID-19. “It felt like someone was sitting on my chest and I couldn’t get any air,” Kelley said of the disease. (AP Photo/Justin Merriman)
'Desperation science' slows the hunt for coronavirus drugs

By Marilynn Marchione Jul. 08, 2020 01:09 AM EDT

THIS CORRECTS THE SPELLING OF THE LAST NAME TO KELLEY, AND NOT KELLY AS ORIGINALLY SENT - Doris Kelley, 57, sits in her home on Monday, June 29, 2020 in Ruffs Dale, Pa. Kelley was one of the first patients in a University of Pittsburgh Medical Center trial for COVID-19. “It felt like someone was sitting on my chest and I couldn’t get any air,” Kelley said of the disease. (AP Photo/Justin Merriman)
'Desperation science' slows the hunt for coronavirus drugs

By Marilynn Marchione Jul. 08, 2020 01:07 AM EDT

FILE - In this May 15, 2020, file photo, Brazil's President Jair Bolsonaro wears a mask amid the COVID-19 pandemic during an event at Planalto presidential palace in Brasilia, Brazil. Bolsonaro said Tuesday, July 7, he tested positive for COVID-19 after months of downplaying the virus’s severity while deaths mounted rapidly inside the country. (AP Photo/Eraldo Peres, File)
Brazil's president, infected with virus, touts malaria drug

By Marcelo De Sousa And David Biller Jul. 08, 2020 12:01 AM EDT

FILE - In this April 9, 2020 file photo, a chemist displays hydroxychloroquine tablets in New Delhi, India. U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19. The Food and Drug Administration said Monday, June 15 that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. (AP Photo/Manish Swarup, File)
US revokes emergency use of drugs touted by Trump vs. virus

By Matthew Perrone Jun. 15, 2020 12:04 PM EDT

U.S. health regulators have pulled their emergency authorization for malaria drugs prescribed for the coronavirus

Jun. 15, 2020 11:56 AM EDT
WASHINGTON (AP) — U.S. health regulators have pulled their emergency authorization for malaria drugs prescribed for the coronavirus. ...

FILE - In this March 16, 2020 file photo, a health worker gives a polio vaccine to a child in Lahore, Pakistan. For millions of people who live in poor and troubled regions of the world, the novel coronavirus is only the latest epidemic. They already face a plethora of fatal and crippling infectious diseases: polio, Ebola, cholera, dengue, tuberculosis and malaria, to name a few. The diseases are made worse by chronic poverty that leads to malnutrition and violence that disrupts vaccination campaigns. (AP Photo/K.M. Chaudary, File)
COVID-19 just the latest epidemic in areas struck by disease

Kathy Gannon Jun. 10, 2020 02:21 AM EDT

FILE - In this April 27, 2020 file photo, jobless people receive food assistance during a government-imposed nationwide lockdown to help contain the spread of the coronavirus, in Quetta, Pakistan. For millions of people who live in poor and troubled regions of the world, the novel coronavirus is only the latest epidemic. They already face a plethora of fatal and crippling infectious diseases: polio, Ebola, cholera, dengue, tuberculosis and malaria, to name a few. The diseases are made worse by chronic poverty that leads to malnutrition and violence that disrupts vaccination campaigns. (AP Photo/Arshad Butt, File)
COVID-19 just the latest epidemic in areas struck by disease

By Kathy Gannon Jun. 10, 2020 02:05 AM EDT

South Dakota drops drug tests to prevent COVID-19

Jun. 05, 2020 02:24 PM EDT
SIOUX FALLS, S.D. (AP) — South Dakota has dropped plans to test an anti-malaria drug to prevent COVID-19, the partners in the study said Friday. ...

FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Friday, June 5, 2020, leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. (AP Photo/John Locher)
Malaria drug didn't help virus patients, big UK study finds

By Marilynn Marchione Jun. 05, 2020 12:34 PM EDT

Update on the latest in business:

Jun. 05, 2020 03:41 AM EDT
FINANCIAL MARKETS Asian shares higher after jobless data snaps Wall St rally UNDATED (AP) — Shares advanced in Asia...

FILE - This April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. A retraction in the journal Lancet on Thursday, June 4, 2020 involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown. (AP Photo/David J. Phillip, File)
Study on safety of malaria drugs for coronavirus retracted

By Marilynn Marchione Jun. 04, 2020 04:18 PM EDT

FILE - In this May 18, 2020 file photo, President Donald Trump tells reporters that he is taking zinc and hydroxychloroquine during a meeting with restaurant industry executives about the coronavirus response, in the State Dining Room of the White House in Washington. Results published Wednesday, June 3, 2020, by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the COVID-19 coronavirus. The drug did not seem to cause serious harm, though - about 40% on it had side effects, mostly mild stomach problems. (AP Photo/Evan Vucci)
Doctors kept close eye on Trump's use of malaria drug

By Kevin Freking Jun. 03, 2020 05:53 PM EDT

Stocks rally...Malaria drug ineffective for covid-19...Germany agrees on stimulus package

Jun. 03, 2020 05:20 PM EDT
NEW YORK (AP) — Stocks rallied again on Wall Street today. The S&P rose 42.05 points or 1.4% to 3,122.87, the latest upward move in its nearly 40% surge...

FILE - In this May 18, 2020 file photo, President Donald Trump tells reporters that he is taking zinc and hydroxychloroquine during a meeting with restaurant industry executives about the coronavirus response, in the State Dining Room of the White House in Washington. Results published Wednesday, June 3, 2020, by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the COVID-19 coronavirus. The drug did not seem to cause serious harm, though - about 40% on it had side effects, mostly mild stomach problems. (AP Photo/Evan Vucci)
Malaria drug fails to prevent COVID-19 in a rigorous study

By Marilynn Marchione Jun. 03, 2020 03:50 PM EDT